Electrotransport delivery device having improved safety and reduced abuse potential

• US 7,027,859 B1
• Filed: 09/26/1994
• Issued: 04/11/2006
• Est. Priority Date: 09/26/1994
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Badzinski, John D., Lattin, Gary A., Reining, William N., McNichols, Larry A., Phipps, Joseph B., Haak, Ronald P
• Primary Examiner(s): Bockelman, Mark
• Application Number:
  US08/312,336
• Time in Patent Office: 4,215 Days
• Field of Search: 604 20- 21, 211/0, 607/152, 607/63
• US Class Current: 604/20
• CPC Class Codes: A61N 1/0412 Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs
• CPC Class Codes: A61N 1/0428 Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
• CPC Class Codes: A61N 1/0436 Material of the electrode
• CPC Class Codes: A61N 1/0448 Drug reservoir
• CPC Class Codes: A61N 1/30 Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
• CPC Class Codes: A61N 1/325 for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body electrodes for external use A61N1/0428

Abstract

An electrotransport device (20) for delivering one or more therapeutic agents through the skin includes electrodes (30,32) for contacting the skin (34), at least one electrode containing the agent, a power source (22) for generating electrical current (I_L) for delivering the agent, a current generating and controlling means (24), and a disabling means (26) for permanently and irreversibly disabling the current. The disabling means (26) may include a timer means (66), a counter means (82), or a body parameter sensor (134) and limit comparator (132) to effect permanent disabling. The disabling means may be a permanent transition to a disabled logic state, a permanent discharge of a power supply source (22), or a permanent diversion of electrotransport current from the electrodes (30,32), or a combination of the above. The permanent disabling means may include a circuit connection means (304,308,326,328) having a frangible conducting member (332) which permanently fractures and causes an irreversible open circuit in the connection to the electrodes (334,342) upon removing a disposable/single use electrode assembly (300) from a reusable portion of an electrotransport device.

Claims

1. An electrotransport device for delivering a therapeutic agent, comprising:

a power source;

first and second electrodes and reservoirs, wherein at least one of the reservoirs contains the therapeutic agent;

a current generating circuit;

a current controlling circuit;

a current enabling circuit;

a current disabling circuit adapted to automatically, permanently and irreversibly disable the current generating circuit upon occurrence of a predetermined event, thereby discontinuing electrotransportation of the agent from the device, said current disabling circuit including a timer circuit, wherein said predetermined event is the expiration of a period of time establishing by said timer circuit; and

a current discharging circuit including a silicon controlled rectifier or a field effect transistor.

2. The device of claim 1, wherein said period of time is from initiation of said timer circuit to a shelf-life.

3. The device of claim 1, wherein the therapeutic agent comprises an abusable drug.

4. The device of claim 3, wherein the abusable drug is a narcotic analgesic.

5. The device of claim 3, wherein said abusable drug is a member selected from the group consisting of fentanyl, sufentanil, carfentanil, lofentanil, alfentanil, hydromorphone, oxycodone, propoxyphene, pentazocine, methadone, tilidine, butorphanol, buprenorphine, levorphanol, codeine, oxymorphone, meperidine, dihydrocodeinone and cocaine.

6. The device of claim 1, wherein the timer circuit can be set to after a predetermined period of time fire a silicon controlled rectifier to discharge a battery to permanently and irreversibly disable the current generating circuit.

7. The method of claim 6, wherein the silicon controlled rectifier is connected to a resistor to discharge the battery.

8. A method of delivering a therapeutic agent by electrotransport, comprising the steps of:

providing an electrotransport device for delivering a therapeutic agent comprising;

a power source;

first and second electrodes and reservoirs, wherein at least one of the reservoirs contains the therapeutic agent;

a current generating circuit;

a current controlling circuit;

a current enabling circuit;

a discharging circuit including a silicon controlled rectifier or a field effect transistor and a current disabling circuit including a timer circuit adapted to automatically, permanently and irreversibly disable the current generating circuit upon occurrence of a predetermined event, thereby discontinuing electrotransportation of the agent from the device; and

automatically, permanently, and irreversibly disabling the current generating circuit upon the occurrence of a predetermined event, thereby discontinuing electrotransportation of the agent from the device.

9. The method of claim 8, wherein said predetermined event comprises the expiration of the shelf-life of the device.

10. The method of claim 8, wherein the timer circuit can be set to after a predetermined period of time fire a silicon controlled rectifier to discharge a battery to permanently and irreversibly disable the current generating circuit.

11. An electrotransport device for delivering a therapeutic agent, comprising:

a power source;

first and second electrodes and reservoirs, wherein at least one of the reservoirs contains the therapeutic agent;

a current generating circuit;

a current controlling circuit;

a current enabling circuit; and

current disabling means adapted to automatically, permanently and irreversibly disable the current generating circuit upon occurrence of a predetermined event, thereby discontinuing electrotransportation of the agent from the device, said disabling means including a timer, wherein said disabling means is activated after said timer measures a predetermined period of time.

12. The device of claim 11, wherein said timer is activated when said current generating circuit is first placed in operation.

13. The device of claim 11, wherein said tinier is activated when the electrotransport device is manufactured.

14. The device of claim 11, wherein the agent comprises an abusable drug.

15. The device of claim 14, wherein said abusable drug comprises a narcotic analgesic.

16. The device of claim 14, wherein said abusable drug is selected from the group consisting of fentanyl, sufentanil, carfentanil, lofentanil, alfentanil, hydromorphone, oxycodone, propoxyphene, pentazocine, methadone, tilidine, butorphanol buprenorphine, levorphanol, codeine, oxymorphone, meperidine, dihyrocodcinone and cocaine.

17. The device of claim 11, wherein the timer circuit can be set to after a predetermined period of time fire a silicon controlled rectifier to discharge a battery to permanently and irreversibly disable the current generating circuit.